Obiltoxaximab

Specification

• Cat#: THA-0030
• Product Name: Obiltoxaximab
• Description: Obiltoxaximab is a monoclonal antibody used for prophylaxis or treatment of inhalational anthrax.
• Sequences: Not Available
• Molecular Weight: 148000.0 Da
• Introduction: Obiltoxaximab, an affinity-enhanced monoclonal antibody (Mab), is used for prevention and treatment of infection and death caused by anthrax toxin. Obiltoxaximab is a chimeric IgG1 kappa monoclonal antibody (mAb) that binds the PA component of B. anthracis toxin. It has an approximate molecular weight of 148 kDa.
• Purity: >99% by SDS-Page and HPLC analysis
• Formula: Not Available
• Appearance: Liquid

Pharmaceutical Information

• Pharmacodynamics: Not Available